Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

What can 6,000 brain scans tell us about Alzheimer's?

KARI's multimodal imaging dataset reveals critical insights into Alzheimer's disease, linking amyloid, tau, and brain structure to cognitive performance.

23 Oct 2026

Modulating GPCR signaling could help delay multiple age-related diseases

Researchers have outlined a bold plan for slowing aging by targeting one of the body's most important cellular communication systems.

22 Oct 2026

New national trial platform aims to accelerate Alzheimer's disease prevention

Researchers from the University of California San Diego will join a collaboration as part of a federal award of up to $41 million to launch a national effort aimed at accelerating the search for treatments that could prevent or slow Alzheimer's disease.

22 Oct 2026

Duke initiative aims to bring dementia AI tools into clinical practice

Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have successfully moved from research into routine clinical practice.

21 Oct 2026

Alzheimer’s biomarkers may help predict disease progression in ALS

Amyotrophic lateral sclerosis (ALS) is a serious neurodegenerative disease in which the nerve cells that control the body's muscles break down.

20 Oct 2026

Researchers investigate molecular mechanisms linking high-calorie diets to cognitive decline

The molecular mechanisms linking a high calorie diet to cognitive impairment remain unclear. Researchers at Institute of Science Tokyo, Japan, investigated this association in mice, finding that the diet reduced nuclear protein PQBP1 expression, disrupting the alternative splicing of genes involved in synaptic function.

20 Oct 2026

Scientists restore memory-linked neuron function in Alzheimer's mice

Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that mimic key features of Alzheimer's disease, showing early promise for the development of a similar targeted therapy in humans.

15 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

Chemists at the University of Bath have discovered how tiny molecular changes can transform the color and brightness of fluorescent probes based on the blue molecule azulene, paving the way for more powerful imaging tools for detecting diseases such as Alzheimer's, Parkinson’s and cancer.

14 Oct 2026

$5.8 million study explores gut-brain inflammation in people with HIV

Oregon Health & Science University researchers have secured a $5.8 million, five-year federal award to investigate whether damage to the gastrointestinal tract contributes to neuroinflammation in people living with HIV - raising the potential for new treatments to preserve brain function in people with HIV and older adults.

13 Oct 2026

Women with polyendocrine metabolic ovarian syndrome more likely to have Alzheimer's and dementia

Alzheimer's disease and dementia may be more common in women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), according to a review of existing evidence published in the Journal of the Endocrine Society.

13 Oct 2026

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

A research "super team" co-led by theBuck Institute for Research on Aging and Georgetown University has received an award of up to $51.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to predict how disease-causing proteins misfold before irreversible damage occurs and use those predictions to develop novel diagnostics and treatments.

12 Oct 2026

Routine blood test may offer clues to future dementia risk

A common blood test already carried out during routine health checks may contain clues about a person's long-term risk of dementia, according to research being presented at the ECNP Congress in Munich and recently published in the Journal of Alzheimer's Disease.

9 Oct 2026

Friends of BrainHealth grants advance dementia prevention and brain health research

For nearly 20 years, the Friends of BrainHealth donor circle has helped turn promising ideas into innovative brain health research.

9 Oct 2026

Sutter Health care model safely expands local Alzheimer's treatment

A multidisciplinary care model developed across Sutter Health helped general neurologists address a practical challenge facing health systems nationwide: how to safely offer newer Alzheimer's disease treatments in community settings to more patients.

9 Oct 2026

Early-onset Alzheimer's patients accumulate symptoms years before diagnosis

People who develop Alzheimer's disease before the age of 65 experience a growing range of health problems and increasing use of healthcare services years before diagnosis.

9 Oct 2026

New modeling reveals high societal value of early Alzheimer's care

New treatments that can slow the progression of Alzheimer's disease could provide significant lifetime benefits to patients and society, with even greater benefits when initiated earlier, according to new research from the USC Schaeffer Center for Health Policy & Economics.

7 Oct 2026

Study finds β-synuclein as early blood-based biomarker of Alzheimer's in Down syndrome patients

Decades before the first symptoms of Alzheimer's disease appear, some changes associated with the disease may begin to leave a trace in the blood.

7 Oct 2026

Could speech offer a window into aging?

Research on speech clocks shows promise for aging biomarkers, connecting speech age gaps to dementia phenotypes and social factors in a large cohort study.

7 Oct 2026

Overweight dementia patients likely to live longer than normal weight peers

People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal weight range, according to a new study by Columbia University Mailman School of Public Health and NYU School of Global Public Health.

6 Oct 2026

Alzheimer's Disease News and Research

Further Reading

What can 6,000 brain scans tell us about Alzheimer's?

Modulating GPCR signaling could help delay multiple age-related diseases

New national trial platform aims to accelerate Alzheimer's disease prevention

Duke initiative aims to bring dementia AI tools into clinical practice

Alzheimer’s biomarkers may help predict disease progression in ALS

Researchers investigate molecular mechanisms linking high-calorie diets to cognitive decline

Scientists restore memory-linked neuron function in Alzheimer's mice

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

$5.8 million study explores gut-brain inflammation in people with HIV

Women with polyendocrine metabolic ovarian syndrome more likely to have Alzheimer's and dementia

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

Routine blood test may offer clues to future dementia risk

Friends of BrainHealth grants advance dementia prevention and brain health research

Sutter Health care model safely expands local Alzheimer's treatment

Early-onset Alzheimer's patients accumulate symptoms years before diagnosis

New modeling reveals high societal value of early Alzheimer's care

Study finds β-synuclein as early blood-based biomarker of Alzheimer's in Down syndrome patients

Could speech offer a window into aging?

Overweight dementia patients likely to live longer than normal weight peers

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News